Indications, contraindications and performance: European Guidelines for Sclerotherapy in Chronic Venous Disorders*

Phlebology

Volumn 29, Issue S1, 2014, Pages 26-33

  Rabe, E ^a   Pannier, F ^b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Chronic venous disease; foam sclerotherapy; sclerotherapy; varicose veins

Indexed keywords

POLIDOCANOL; SCLEROSING AGENT; SODIUM TETRADECYL SULPHATE; UNCLASSIFIED DRUG; TETRADECYL SULFATE SODIUM;

ALLERGY; ARTERIOVENOUS MALFORMATION; BREAST FEEDING; CHRONIC DISEASE; DEEP VEIN THROMBOSIS; DISEASE PREDISPOSITION; EVIDENCE BASED PRACTICE; FOAM; HEART RIGHT LEFT SHUNT; HUMAN; IMMOBILITY; INFECTION; INJECTION; MEDICAL SOCIETY; NEUROLOGIC DISEASE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SCLEROTHERAPY; TELANGIECTASIA; THROMBOEMBOLISM; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VARICOSIS; VEIN DISEASE; VEIN GRAFT DISEASE; VEIN THROMBOSIS; EUROPE; EVIDENCE BASED MEDICINE; VEIN MALFORMATION;

EID: 84901022566     PISSN: 02683555     EISSN: 14333031     Source Type: Journal    
DOI: 10.1177/0268355514528127     Document Type: Review

References (57)

1. Guyatt G,Gutterman D,Baumann MH,Addrizzo-Harris D,Hylek EM,Phillips B,Raskob G,Zelman Lewis S,Schünemann H.Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines: Report From an American College of Chest Physicians Task Force.Chest. 2006;129:174-181.
2. Drake LA,Dinehart SM,Goltz RW,Graham GF,Hordinsky MK,Lewis CW,Pariser DM,Skouge JW,Webster SB,Whitaker DC,Franceschi C.Guidelines of care for sclerotherapy treatment of varicose and teleangiectatic leg veins.J Am Acad Dermatol. 1996;34:523-528.
3. Rabe E,Pannier-Fischer F,Gerlach H, et al.Guidelines for sclerotherapy of varicose veins.Dermatol Surg. 2004;30:687-693.
4. Hamel-Desnos C,Ouvry P,Benigni JP,Boitelle G,Schadeck M,Desnos P,Allaert FA.Comparison of 1% and 3% Polidocanol Foam in Ultrasound Guided Sclerotherapy of the Great Saphenous Vein: A Randomised, Double-Blind Trial with 2 Year-Follow-up. "The 3/1 Study".Eur J Vasc Endovasc Surg. 2007;34:723-729.
5. Chen C-H.,Chiu C-S,Yang C-H.Ultrasound-Guided Foam Sclerotherapy for Treating Incompetent Great Saphenous Veins - Results of 5 Years of Analysis and Morphologic Evolvement Study.Dermatol Surg. 2012;38:851-857.
6. Hamel-Desnos C,Desnos P,Wollmann JC,Quvry P,Mako S,Allaert FA.Evaluation of the efficacy of Polidocanol in the form of foam compared with liquid form in sclerotherapy of the long saphenous vein: Initial results.Dermatol Surg. 2003;29:1170-1175.
7. Alos J,Carreno P,Lopez JA, et al.Efficacy and safety of sclerotherapy using Polidocanol foam: A controlled clinical trial.Eur J Vasc Endovasc Surg. 2006;31:101-107.
8. Ouvry P,Allaert FA,Desnos P,Hamel-Desnos C.Efficacy of Polidocanol Foam versus Liquid in Sclerotherapy of the Great Saphenous Vein: A Multicenter Randomised Controlled Trial with a 2-year Follow-up.Eur J Vasc Surg. 2008;36:366-370.
9. Rabe E,Otto J,Schliephake D,Pannier F.Efficacy and Safety of Great Saphenous Vein Sclerotherapy Using Standardised Polidocanol Foam (ESAF): A Randomised Controlled Multicentre Clinical Trial.Eur J Endovasc Vasc Surg. 2008;35:238-245.
10. Rasmussen LH, et al.Randomized clinical trial comparing endovenous laser ablation,radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins.Br. J. Surg. 2011;98:1079-1087.
11. Shadid N,Ceulen R,Nelemans P,Dirksen C,Veraart J,Schurink GW,van Neer P,Vd Kley J,de Haan E,Sommer A.Randomized clinical trial of ultrasound-guided foam sclerotherapy versus surgery for the incompetent great saphenous vein.Br J Surg. 2012;99:1062-1070.
12. Myers KA,Jolley D,Clough A,Kirwan J.Outcome of Ultrasound-guided Sclerotherapy for Varicose Veins: Medium-term Results Assessed by Ultrasound Surveillance.Eur J Vasc Endovasc Surg. 2007;33:116-121.
13. Zhang J,Jing Z,Schliephake DE,Otto J,Malouf GM,Gu YQ.Efficacy and safety of Aethoxysklerol® (polidocanol) 0.5%, 1% and 3% in comparison with placebo solution for the treatment of varicose veins of the lower extremities in Chinese patients (ESA-China Study).Phlebology. 2012;27:184-190.
14. Guex JJ.Ultrasound Guided Sclerotherapy (USGS) for Perforating Veins.Hawaii Med J. 2000;59:261-262.
15. Masuda EM,Kessler DM,Lurie F,Puggioni A,Kistner RL,Eklof B.The effect of ultrasound guided sclerotherapy of incompetent perforator veins on venous clinical severity scores.J Vasc Surg. 2006;43:551-556.
16. Van Neer P,Veraart JCJM,Neumann H.Posterolateral thigh perforator varicosities in 12 patients: A normal deep venous system and successful treatment with ultrasound-guided sclerotherapy.Dermatol Surg. 2006;32:1346-1352.
17. Kahle B,Leng K.Efficacy of sclerotherapy in varicose veins - a prospective, blinded placebocontrolled study.Dermatol Surg. 2004;30:723-728.
18. Norris MJ,Carlin MC,Ratz JL.Treatment of essential telangiectasias: Effects of increasing concentrations of polidocanol.J Am Acad of Dermatol. 1989;20:643-649.
19. Rabe E,Schliephake D,Otto J,Breu FX,Pannier F.Sclerotherapy of telangiectasias and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study).Phlebology. 2010;25:124-131.
20. Uncu H.Sclerotherapy: A study comparing polidocanol in foam and liquid form.Phlebology. 2010;25:44-49.
21. Peterson JD,Goldman MP,Weiss RA,Duffy DM,Fabi SG,Weiss MA,Guiha I.Treatment of Reticular and Telangiectatic Leg Veins: Double-Blind, Prospective Comparative Trial of Polidocanol and Hypertonic Saline.Dermatol Surg. 2012;38:1-9.
22. Kakkos SK,Bountouroglou DG,Azzam M,Kalodiki E,Daskalopoulos M,Geroulakos G.Effectiveness and Safety of Ultrasound-Guided Foam Sclerotherapy for Recurrent Varicose Veins: Immediate Results.Journal of Endovascular Therapy. 2006;13:357-364.
23. McDonagh B,Sorenson S,Gray C,Huntley DE,Putterman P,King T,Eaton T,Martin C,Harry JL,Cohen A,Guptan RC.Clinical spectrum of recurrent postoperative varicose veins and efficacy of sclerotherapy management using the compass technique.Phlebology. 2003;18:173-186.
24. Coleridge Smith P.Chronic Venous Disease Treated by Ultrasound Guided Foam Sclerotherapy.Eur J Vasc Endovasc Surg. 2006;32:577-583.
25. Coleridge Smith P.Sclerotherapy and foam sclerotherapy for varicose veins.Phlebology. 2009;24:260-269.
26. Bradbury AW,Bate G,Pang K,Darvall KA,Adam DJ.Ultrasound-guided foam sclerotherapy is a safe and clinically effective treatment for superficial venous reflux.J Vasc Surg. 2010;52:939-945.
27. Darvall KA,Bate GR,Adam DJ,Silverman SH,Bradbury AW.Duplex ultrasound outcomes followin ultrasound guided foam sclerotherapyof symptomatic recurrent great saphenous varicose veins.Eur J Vasc Endovasc Surg. 2011;42:107-114.
28. Sukovatykh BS,Rodionov OA,Sukovatykh MB,Khodykin SP.Diagnosis and treatment of atypical forms of varicose disease of pelvic veins.Vestnik Khirurgii Imeni i - i - Grekova. 2008;167:43-45.
29. Paraskevas P.Successful ultrasound-guided foam sclerotherapy for vulval and leg varicosities secondary to ovarian vein reflux: a case study.Phlebology. 2011;26:29-31.
30. Stücker M,Reich S,Hermes N, et al.Safety and efficiency of perilesional sclerotherapy in leg ulcer patients with postthrombotic syndrome and/or oral anticoagulation with Phenprocoumon.JDDG. 2006;4:734-738.
31. De Waard MM,Der Kinderen DJ.Duplex ultrasonography-guided foam sclerotherapy of incompetent perforator veins in a patient with bilateral venous leg ulcers.Dermatol Surg. 2005;31:580-583.
32. Hertzman PA,Owens R.Rapid healing of chronic venous ulcers following ultrasound-guided foam sclerotherapy.Phlebology. 2007;22:34-39.
33. Pang KH,Bate GR,Darvall KAL,Adam DJ,Bradbury AW.Healing and recurrence rates following ultrasound guided foam sclerotherapy of superficial venous reflux in patients with chronic venous ulceration.Eur J Vasc endovasc Surg. 2010;40:790-795.
34. Yamaki T,Nozaki M,Sasaki K.Color duplex-guided sclerotherapy for the treatment of venous malformations.Dermatol Surg. 2000;26:323-328.
35. Yamaki T,Nozaki M,Sakurai H, et al.Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations.J Vasc Surg. 2008;47:578-584.
36. Blaise S,Charavin-Cocuzza M,Riom H,Brix M,Seinturier C,Diamand JM,Gachet G,Carpentier PH.Treatment of Low-flow Vascular Malformations by Ultrasound-guided Sclerotherapy with Polidocanol Foam: 24 Cases and Literature Review.Eur J Vasc Endovasc Surg. 2011;41:412-417.
37. Kern P,Ramelet A-A,Wutschert R,Bounameaux H,Hayoz D.Single blind randomized study comparing chromated glycerin, polidocanol solution and polidocanol foam for treatment of telangiectactic leg veins.Dermatol Surg. 2004;30:367-372.
38. Rabe E, Pannier F, Gerlach H, Breu FX, Guggenbichler S, Wollmann JC. Leitlinie Sklerosierungsbehandlung der Varikose Phlebologie 2008; 37: 27-34.
39. Rao J,Wildemore JK,Goldmann MP.Double-blind prospective comparative trial between foamed and liquid Polidocanol and Natrium Tetradecyl Sulfate in the treatment of varicose and telangiectatic leg veins.Dermatol Surg. 2005;31:631-635.
40. Bullens-Goessens YIJM,Mentink LF, et al.Ultrasound-guided sclerotherapy of the insufficient short saphenous vein.Phlebologie Germany. 2004;33:89-91.
41. Schultz-Ehrenburg U,Tourbier H.Doppler-kontrollierte Verödungsbehandlung der Vena saphena magna.Phlebol u Proktol. 1984;13:117-122.
42. Vin F.Principes de la Sclérothéraphie des Troncs Saphènes Internes.Phlébologie. 1997;50,2:229-234.
43. Gohel MS,Epstein DM,Davies AH.Cost-effectiveness of traditional and endovenous treatments for varicose veins.Br J Surg. 2010;97:1815-1823.
44. Wright D,Gobin JP,Bradbury AW, et al.Varisolve European Phase III Investigators Group. Varisolve® polidocanol microfoam compared with surgery or sclerotherapy in the management of varicose veins in the presence of trunk vein incompetence: European randomized controlled trial.Phlebology. 2006;21:180-190.
45. Cavezzi A,Frullini A,Ricci S,Tessari L.Treatment of varicose veins by foam sclerotherapy: Two clinical series.Phlebology. 2002;17:13-8.
46. Hamel-Desnos C,Ouvry P,Desnos P, et al.Sclérothérapie et thrombophilie: Démarche pour un consensus dans la sclérothérapie chez les thrombophiles.Phlébologie. 2003;56: 165-69.
47. Breu FX,Guggenbichler S,Wollmann JC.2nd European Consensus Meeting on Foam Sclerotherapy, 28-30 April 2006, Tegernsee, Germany.Vasa. 2008;37:1-32.
48. Guex JJ.Les contre-indications de la sclérothérapie, mise à jour 2005.J Mal Vasc. 2005;30:144-149.
49. Hamel-Desnos CM,Gillet J-L,Desnos PR,Allaert FA.Sclerotherapy of varicose veins in patients with documented thrombophilia: a prospective controlled randomized study of 105 cases.Phlebology. 2009;24:176-182.
50. Gachet G,Spini L.Sclérothérapie des varices sous anticoagulants.Phlébologie. 2002;55:41-44.
51. Kreussler: Fachinformationen Aethoxysklerol 0,25%/0,5%/1%/2%/3% Stand Oktober 2009, Chemische Fabrik Kreussler & Co GmbH.
52. STD Pharmaceutical Products Ltd. Prescribing Information March 2012.
53. Guex JJ,Hamel-Desnos C,Gillet JL,Chleir F,Perrin M.Sclérothérapie des varices par mousse écho-guidée: techniques de mise en œuvre, indications, résultats publiés.Phlébologie. 2008;61:261-270.
54. Yamaki T,Hamahata A,Soejima K,Kono T,Nozaki M,Sakurai H.Prospective Randomised Comparative Study of Visual Foam Sclerotherapy Alone or in Combination with Ultrasound-guided Foam Sclerotherapy for Treatment of Superficial Venous Insufficiency: Preliminary Report.EJVES. 2012;43:343-347.
55. Myers KA,Jolley D.Factors Affecting the Risk of Deep Venous Occlusion after Ultrasound-guided Sclerotherapy for Varicose Vein.Eur J Vasc Endovasc Surg. 2008;36:602-605.
56. Tessari L,Cavezzi A,Frullini A.Preliminary experience with a new sclerosing foam in the treatment of varicose veins.Dermatol Surg. 2001;27:58-60.
57. Rathbun S,Norris A,Stoner J.Efficacy and safety of endovenous foam sclerotherapy: meta-analysis for treatment of venous disorders.Phlebology. 2012;27:105-117.